Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 6 | 2022 | 13 | 1.500 |
Why?
|
| Neuralgia | 3 | 2020 | 9 | 0.900 |
Why?
|
| Complex Regional Pain Syndromes | 6 | 2022 | 20 | 0.870 |
Why?
|
| Ganglia, Spinal | 6 | 2022 | 58 | 0.700 |
Why?
|
| Analgesia, Epidural | 8 | 2003 | 54 | 0.590 |
Why?
|
| Pain, Postoperative | 8 | 2003 | 272 | 0.500 |
Why?
|
| Chronic Pain | 4 | 2022 | 127 | 0.490 |
Why?
|
| Equipment Failure | 1 | 2016 | 34 | 0.480 |
Why?
|
| Ketamine | 2 | 2018 | 23 | 0.460 |
Why?
|
| Analgesics | 6 | 2018 | 78 | 0.420 |
Why?
|
| Electric Stimulation Therapy | 4 | 2018 | 39 | 0.370 |
Why?
|
| Low Back Pain | 3 | 2022 | 129 | 0.340 |
Why?
|
| Humans | 40 | 2022 | 22932 | 0.300 |
Why?
|
| Pain, Intractable | 3 | 2007 | 9 | 0.260 |
Why?
|
| Pain Management | 4 | 2018 | 126 | 0.210 |
Why?
|
| Pain | 7 | 2022 | 332 | 0.210 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2003 | 20 | 0.200 |
Why?
|
| Pain Measurement | 8 | 2022 | 412 | 0.170 |
Why?
|
| Denmark | 1 | 2020 | 9 | 0.170 |
Why?
|
| Peripheral Nervous System Diseases | 2 | 2012 | 27 | 0.160 |
Why?
|
| Anesthesia, Epidural | 2 | 2011 | 18 | 0.150 |
Why?
|
| Nerve Block | 4 | 2000 | 61 | 0.140 |
Why?
|
| Spinal Stenosis | 1 | 2018 | 35 | 0.140 |
Why?
|
| Anesthesiologists | 1 | 2018 | 6 | 0.140 |
Why?
|
| Prospective Studies | 7 | 2022 | 1493 | 0.140 |
Why?
|
| Anesthesia, Conduction | 1 | 2018 | 30 | 0.140 |
Why?
|
| Societies, Medical | 1 | 2018 | 117 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 235 | 0.130 |
Why?
|
| Cohort Studies | 1 | 2020 | 1417 | 0.120 |
Why?
|
| Retrospective Studies | 6 | 2022 | 2995 | 0.120 |
Why?
|
| Testicular Diseases | 1 | 1996 | 13 | 0.120 |
Why?
|
| Denervation | 1 | 1996 | 20 | 0.120 |
Why?
|
| Spermatic Cord | 1 | 1996 | 15 | 0.120 |
Why?
|
| Microsurgery | 1 | 1996 | 39 | 0.120 |
Why?
|
| Spinal Fusion | 1 | 2022 | 429 | 0.120 |
Why?
|
| Consensus | 3 | 2022 | 81 | 0.110 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 10 | 0.110 |
Why?
|
| Bupivacaine | 3 | 1994 | 39 | 0.110 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 47 | 0.110 |
Why?
|
| Thoracotomy | 1 | 1994 | 30 | 0.110 |
Why?
|
| Lactones | 2 | 2005 | 9 | 0.110 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2005 | 25 | 0.110 |
Why?
|
| Adult | 13 | 2022 | 6931 | 0.110 |
Why?
|
| Morphine | 2 | 1992 | 70 | 0.100 |
Why?
|
| Middle Aged | 12 | 2022 | 7915 | 0.100 |
Why?
|
| Female | 15 | 2022 | 12958 | 0.090 |
Why?
|
| International Normalized Ratio | 1 | 2011 | 17 | 0.090 |
Why?
|
| Catheterization | 1 | 2011 | 40 | 0.090 |
Why?
|
| Warfarin | 1 | 2011 | 25 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 20 | 0.080 |
Why?
|
| Male | 13 | 2022 | 12460 | 0.080 |
Why?
|
| Psychometrics | 1 | 2010 | 176 | 0.080 |
Why?
|
| Benzocaine | 2 | 2000 | 4 | 0.080 |
Why?
|
| Perioperative Nursing | 1 | 1989 | 3 | 0.080 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 137 | 0.080 |
Why?
|
| Narcotics | 1 | 1990 | 34 | 0.080 |
Why?
|
| Anesthetics, Local | 2 | 2000 | 71 | 0.070 |
Why?
|
| Neoplasms | 2 | 1998 | 218 | 0.070 |
Why?
|
| Sulfones | 2 | 2005 | 20 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 801 | 0.070 |
Why?
|
| Terrorism | 1 | 2007 | 9 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2007 | 74 | 0.070 |
Why?
|
| Analgesia | 1 | 2007 | 34 | 0.070 |
Why?
|
| Reflex Sympathetic Dystrophy | 2 | 1996 | 2 | 0.060 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 49 | 0.060 |
Why?
|
| Depressive Disorder | 1 | 2007 | 163 | 0.060 |
Why?
|
| Treatment Outcome | 4 | 2022 | 2941 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2010 | 311 | 0.060 |
Why?
|
| Aged | 7 | 2022 | 7449 | 0.060 |
Why?
|
| Injections, Epidural | 2 | 2018 | 15 | 0.050 |
Why?
|
| Sympatholytics | 2 | 2010 | 7 | 0.050 |
Why?
|
| Isoenzymes | 1 | 2003 | 50 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2022 | 210 | 0.050 |
Why?
|
| Clonidine | 2 | 1996 | 17 | 0.050 |
Why?
|
| Sacroiliac Joint | 1 | 2022 | 6 | 0.050 |
Why?
|
| Upper Extremity | 1 | 2022 | 52 | 0.050 |
Why?
|
| Device Removal | 1 | 2022 | 68 | 0.050 |
Why?
|
| Fentanyl | 2 | 1994 | 24 | 0.040 |
Why?
|
| Celiac Plexus | 1 | 2000 | 1 | 0.040 |
Why?
|
| Extremities | 2 | 1996 | 24 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2000 | 88 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 592 | 0.040 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 117 | 0.030 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2003 | 560 | 0.030 |
Why?
|
| Thermography | 1 | 1996 | 8 | 0.030 |
Why?
|
| Time Factors | 2 | 1992 | 1261 | 0.030 |
Why?
|
| Blood Pressure | 3 | 1996 | 166 | 0.030 |
Why?
|
| Parasympatholytics | 1 | 1996 | 3 | 0.030 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1996 | 12 | 0.030 |
Why?
|
| Chronic Disease | 4 | 1998 | 375 | 0.030 |
Why?
|
| Anesthesia, Spinal | 1 | 2015 | 15 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2018 | 292 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 3729 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2015 | 29 | 0.030 |
Why?
|
| Yohimbine | 2 | 1996 | 6 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 324 | 0.030 |
Why?
|
| Patient Care Team | 1 | 1994 | 110 | 0.020 |
Why?
|
| United States | 1 | 2018 | 1765 | 0.020 |
Why?
|
| Infusions, Parenteral | 2 | 1989 | 10 | 0.020 |
Why?
|
| Algorithms | 1 | 1994 | 304 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1992 | 52 | 0.020 |
Why?
|
| Oxygen | 1 | 1992 | 56 | 0.020 |
Why?
|
| Catheters, Indwelling | 1 | 2011 | 20 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 1992 | 81 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 1991 | 32 | 0.020 |
Why?
|
| Guanethidine | 1 | 2010 | 1 | 0.020 |
Why?
|
| Vasodilation | 1 | 2010 | 6 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2010 | 34 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 56 | 0.020 |
Why?
|
| Subarachnoid Space | 1 | 1990 | 4 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 1653 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 67 | 0.020 |
Why?
|
| Nociceptors | 1 | 1990 | 19 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 442 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 309 | 0.020 |
Why?
|
| Subdural Space | 1 | 1988 | 1 | 0.020 |
Why?
|
| Embolism, Air | 1 | 1988 | 10 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 761 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2007 | 22 | 0.020 |
Why?
|
| September 11 Terrorist Attacks | 1 | 2007 | 7 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2007 | 107 | 0.020 |
Why?
|
| Causality | 1 | 2007 | 43 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2003 | 373 | 0.020 |
Why?
|
| Patient Selection | 1 | 2007 | 167 | 0.020 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 163 | 0.020 |
Why?
|
| Adaptation, Psychological | 2 | 1996 | 166 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 548 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 730 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2007 | 811 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2005 | 58 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2005 | 96 | 0.010 |
Why?
|
| Stress, Psychological | 2 | 1996 | 207 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 865 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 219 | 0.010 |
Why?
|
| Dyssomnias | 1 | 2003 | 5 | 0.010 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 23 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 29 | 0.010 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2003 | 22 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2003 | 16 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1988 | 437 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 2003 | 53 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2003 | 42 | 0.010 |
Why?
|
| Injections, Spinal | 2 | 1996 | 33 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1988 | 354 | 0.010 |
Why?
|
| Reaction Time | 2 | 1996 | 78 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2003 | 140 | 0.010 |
Why?
|
| Adolescent | 1 | 1988 | 1882 | 0.010 |
Why?
|
| Hemodynamics | 2 | 1996 | 54 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2003 | 257 | 0.010 |
Why?
|
| Range of Motion, Articular | 1 | 2003 | 564 | 0.010 |
Why?
|
| Suspensions | 1 | 1998 | 3 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 68 | 0.010 |
Why?
|
| Discriminant Analysis | 1 | 1996 | 9 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 28 | 0.010 |
Why?
|
| Cold Temperature | 1 | 1996 | 27 | 0.010 |
Why?
|
| Body Temperature | 1 | 1996 | 39 | 0.010 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1996 | 17 | 0.010 |
Why?
|
| Biofeedback, Psychology | 1 | 1996 | 5 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1996 | 13 | 0.010 |
Why?
|
| Pain Clinics | 1 | 1996 | 4 | 0.010 |
Why?
|
| Behavior | 1 | 1996 | 21 | 0.010 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1996 | 16 | 0.010 |
Why?
|
| Dioxanes | 1 | 1996 | 2 | 0.010 |
Why?
|
| Glycopyrrolate | 1 | 1996 | 2 | 0.010 |
Why?
|
| Idazoxan | 1 | 1996 | 2 | 0.010 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1996 | 4 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1996 | 14 | 0.010 |
Why?
|
| Physical Therapy Modalities | 1 | 1996 | 58 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1996 | 19 | 0.010 |
Why?
|
| Animals | 2 | 1996 | 3270 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1996 | 50 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 1996 | 88 | 0.010 |
Why?
|
| Bradycardia | 1 | 1996 | 21 | 0.010 |
Why?
|
| Learning | 1 | 1996 | 59 | 0.010 |
Why?
|
| Dogs | 1 | 1996 | 136 | 0.010 |
Why?
|
| Family | 1 | 1996 | 85 | 0.010 |
Why?
|
| Wakefulness | 1 | 1996 | 68 | 0.010 |
Why?
|
| Heart Rate | 1 | 1996 | 104 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 295 | 0.010 |
Why?
|
| Imidazoles | 1 | 1996 | 62 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 313 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1992 | 12 | 0.010 |
Why?
|
| Reperfusion | 1 | 1992 | 7 | 0.010 |
Why?
|
| Oximetry | 1 | 1992 | 10 | 0.010 |
Why?
|
| Hypotension | 1 | 1992 | 20 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 1996 | 1021 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 1992 | 59 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 33 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 1992 | 64 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 103 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1990 | 25 | 0.010 |
Why?
|
| Cognition | 1 | 1996 | 948 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1988 | 18 | 0.000 |
Why?
|
| Rats | 1 | 1990 | 623 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1988 | 31 | 0.000 |
Why?
|
| Epidural Space | 1 | 1988 | 19 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 102 | 0.000 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 3 | 0.000 |
Why?
|
| Veins | 1 | 1988 | 8 | 0.000 |
Why?
|
| Mass Spectrometry | 1 | 1988 | 24 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1988 | 204 | 0.000 |
Why?
|
| Incidence | 1 | 1988 | 624 | 0.000 |
Why?
|
| Hip Joint | 1 | 1988 | 242 | 0.000 |
Why?
|